What is the typical course of Keflex (cephalexin) for an uncomplicated urinary tract infection (UTI) in an adult patient with normal renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Keflex Course for Uncomplicated UTI

For uncomplicated cystitis in adults with normal renal function, prescribe cephalexin 500 mg every 12 hours for 7 to 14 days. 1

Dosing Regimen

  • Standard dose: Cephalexin 500 mg orally every 12 hours 1
  • Duration: 7 to 14 days for uncomplicated cystitis 1
  • Alternative dosing: 250 mg every 6 hours is also FDA-approved, but the twice-daily regimen improves adherence without compromising efficacy 1, 2

Recent evidence demonstrates that twice-daily dosing (500 mg BID) is as effective as four-times-daily dosing (500 mg QID) for uncomplicated UTI, with no difference in treatment failure rates (12.7% vs 17%, p=0.343) 2. The twice-daily regimen offers the practical advantage of improved patient compliance while maintaining therapeutic efficacy.

Important Clinical Context

Cephalexin is NOT a first-line agent for uncomplicated UTI. Current guidelines from the Infectious Diseases Society of America classify β-lactam antibiotics, including cephalexin, as alternative rather than first-line therapy 3. First-line agents include:

  • Nitrofurantoin (preferred)
  • Trimethoprim-sulfamethoxazole (if local resistance <20%) 3
  • Fosfomycin 3

When Cephalexin Is Appropriate

Use cephalexin when first-line agents cannot be used due to:

  • Documented resistance patterns 3
  • Patient allergies to preferred agents 3
  • Local resistance rates exceeding thresholds for fluoroquinolones or trimethoprim-sulfamethoxazole 3

Pharmacologic Rationale

Cephalexin achieves urinary concentrations of 500-1000 mcg/mL following 250-500 mg oral doses, far exceeding the minimum inhibitory concentration for common uropathogens 4. It is completely absorbed in the upper intestine and 70-100% is excreted unchanged in urine within 6-8 hours 4. This excellent urinary penetration supports its efficacy despite being a second-line agent 5.

Critical Caveats

  • Do NOT use cephalexin for pyelonephritis: Oral cephalosporins achieve significantly lower blood concentrations than IV formulations and are not adequately studied for upper tract infections 3. For pyelonephritis, use cefpodoxime 200 mg BID for 10 days or ceftibuten 400 mg daily for 10 days, preferably with an initial IV dose of ceftriaxone 3

  • Renal dosing required: Patients with creatinine clearance <30 mL/min require dose reduction proportional to renal function 4

  • Verify susceptibility: Always obtain urine culture before initiating therapy when possible, as cephalexin resistance varies geographically 3

  • Males and complicated UTI: For men or patients with complicating factors (diabetes, immunosuppression, anatomic abnormalities), consider 7-14 days of therapy, with 14 days preferred when prostatitis cannot be excluded 3

Duration Considerations

While the FDA label states 7-14 days 1, emerging data on short-course therapy for complicated UTI suggests 7 days may be sufficient for most uncomplicated cases 3. However, given cephalexin's status as a second-line agent with less robust efficacy data than fluoroquinolones, err toward 10-14 days for uncomplicated cystitis to ensure adequate treatment and minimize recurrence risk.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Research

Cephalexin in the therapy of infections of the urinary tract.

Postgraduate medical journal, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.